| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-07 16:17:13 UTC |
|---|
| Updated at | 2022-09-07 16:17:14 UTC |
|---|
| NP-MRD ID | NP0252695 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (1s,3r,4ar,4bs,6as,10as,10bs,12as)-3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate |
|---|
| Description | Petrosaspongiolide m belongs to the class of organic compounds known as diterpene lactones. These are diterpenoids containing a lactone moiety. (1s,3r,4ar,4bs,6as,10as,10bs,12as)-3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate is found in Petrosaspongia nigra. (1s,3r,4ar,4bs,6as,10as,10bs,12as)-3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate was first documented in 2003 (PMID: 12770615). Based on a literature review a significant number of articles have been published on petrosaspongiolide m (PMID: 17117584) (PMID: 15857607) (PMID: 24530967) (PMID: 23594598) (PMID: 22438326) (PMID: 20492447). |
|---|
| Structure | CC(=O)O[C@@H]1O[C@H](C[C@@H]2[C@@H]1CC[C@H]1[C@@]2(C)CC[C@H]2C(C)(C)CCC[C@]12C)C1=CC(=O)OC1O InChI=1S/C27H40O6/c1-15(28)31-24-16-7-8-21-26(4,12-9-20-25(2,3)10-6-11-27(20,21)5)18(16)14-19(32-24)17-13-22(29)33-23(17)30/h13,16,18-21,23-24,30H,6-12,14H2,1-5H3/t16-,18+,19+,20-,21-,23?,24+,26-,27-/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C27H40O6 |
|---|
| Average Mass | 460.6110 Da |
|---|
| Monoisotopic Mass | 460.28249 Da |
|---|
| IUPAC Name | (1S,2R,4R,6S,7S,10S,11S,16S)-4-(2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl)-1,11,15,15-tetramethyl-5-oxatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadecan-6-yl acetate |
|---|
| Traditional Name | (1S,2R,4R,6S,7S,10S,11S,16S)-4-(2-hydroxy-5-oxo-2H-furan-3-yl)-1,11,15,15-tetramethyl-5-oxatetracyclo[8.8.0.0^{2,7}.0^{11,16}]octadecan-6-yl acetate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(=O)O[C@@H]1O[C@H](C[C@@H]2[C@@H]1CC[C@H]1[C@@]2(C)CC[C@H]2C(C)(C)CCC[C@]12C)C1=CC(=O)OC1O |
|---|
| InChI Identifier | InChI=1S/C27H40O6/c1-15(28)31-24-16-7-8-21-26(4,12-9-20-25(2,3)10-6-11-27(20,21)5)18(16)14-19(32-24)17-13-22(29)33-23(17)30/h13,16,18-21,23-24,30H,6-12,14H2,1-5H3/t16-,18+,19+,20-,21-,23?,24+,26-,27-/m0/s1 |
|---|
| InChI Key | RVWQZLJUVIFAOY-GQLPRRODSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as diterpene lactones. These are diterpenoids containing a lactone moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Terpene lactones |
|---|
| Direct Parent | Diterpene lactones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Diterpene lactone
- Diterpenoid
- Clerodane diterpenoid
- Naphthopyran
- Naphthalene
- 2-furanone
- Dicarboxylic acid or derivatives
- Oxane
- Pyran
- Dihydrofuran
- Enoate ester
- Alpha,beta-unsaturated carboxylic ester
- Lactone
- Hemiacetal
- Carboxylic acid ester
- Acetal
- Oxacycle
- Carboxylic acid derivative
- Organoheterocyclic compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Alcaraz MJ, Paya M: Marine sponge metabolites for the control of inflammatory diseases. Curr Opin Investig Drugs. 2006 Nov;7(11):974-9. [PubMed:17117584 ]
- Busserolles J, Paya M, D'Auria MV, Gomez-Paloma L, Alcaraz MJ: Protection against 2,4,6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongiolide M. Biochem Pharmacol. 2005 May 15;69(10):1433-40. doi: 10.1016/j.bcp.2005.01.020. [PubMed:15857607 ]
- Monti MC, Margarucci L, Riccio R, Bonfili L, Mozzicafreddo M, Eleuteri AM, Casapullo A: Mechanistic insights on petrosaspongiolide M inhibitory effects on immunoproteasome and autophagy. Biochim Biophys Acta. 2014 Apr;1844(4):713-21. doi: 10.1016/j.bbapap.2014.02.003. Epub 2014 Feb 14. [PubMed:24530967 ]
- Andres RM, Montesinos MC, Navalon P, Paya M, Terencio MC: NF-kappaB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH. J Invest Dermatol. 2013 Oct;133(10):2362-2371. doi: 10.1038/jid.2013.182. Epub 2013 Apr 17. [PubMed:23594598 ]
- Margarucci L, Tosco A, De Simone R, Riccio R, Monti MC, Casapullo A: Modulation of proteasome machinery by natural and synthetic analogues of the marine bioactive compound petrosaspongiolide M. Chembiochem. 2012 May 7;13(7):982-6. doi: 10.1002/cbic.201200113. Epub 2012 Mar 21. [PubMed:22438326 ]
- De Simone R, Andres RM, Aquino M, Bruno I, Guerrero MD, Terencio MC, Paya M, Riccio R: Toward the discovery of new agents able to inhibit the expression of microsomal prostaglandin E synthase-1 enzyme as promising tools in drug development. Chem Biol Drug Des. 2010 Jul;76(1):17-24. doi: 10.1111/j.1747-0285.2010.00984.x. Epub 2010 Apr 28. [PubMed:20492447 ]
- Monti MC, Casapullo A, Cavasotto CN, Tosco A, Dal Piaz F, Ziemys A, Margarucci L, Riccio R: The binding mode of petrosaspongiolide M to the human group IIA phospholipase A(2): exploring the role of covalent and noncovalent interactions in the inhibition process. Chemistry. 2009;15(5):1155-63. doi: 10.1002/chem.200801512. [PubMed:19065693 ]
- Aquino M, Guerrero MD, Bruno I, Terencio MC, Paya M, Riccio R: Development of a second generation of inhibitors of microsomal prostaglandin E synthase 1 expression bearing the gamma-hydroxybutenolide scaffold. Bioorg Med Chem. 2008 Oct 1;16(19):9056-64. doi: 10.1016/j.bmc.2008.08.001. Epub 2008 Aug 6. [PubMed:18790649 ]
- Guerrero MD, Aquino M, Bruno I, Terencio MC, Paya M, Riccio R, Gomez-Paloma L: Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression. J Med Chem. 2007 May 3;50(9):2176-84. doi: 10.1021/jm0700823. Epub 2007 Apr 4. [PubMed:17407277 ]
- Monti MC, Casapullo A, Riccio R, Gomez-Paloma L: PLA2-mediated catalytic activation of its inhibitor 25-acetyl-petrosaspongiolide M: serendipitous identification of a new PLA2 suicide inhibitor. FEBS Lett. 2004 Dec 17;578(3):269-74. doi: 10.1016/j.febslet.2004.10.100. [PubMed:15589831 ]
- Capasso A, Casapullo A, Randazzo A, Gomez-Paloma L: Petrosaspongiolide M reduces morphine withdrawal in vitro. Life Sci. 2003 Jun 20;73(5):611-6. doi: 10.1016/s0024-3205(03)00319-9. [PubMed:12770615 ]
- Posadas I, Terencio MC, Randazzo A, Gomez-Paloma L, Paya M, Alcaraz MJ: Inhibition of the NF-kappaB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M. Biochem Pharmacol. 2003 Mar 1;65(5):887-95. doi: 10.1016/s0006-2952(02)01659-3. [PubMed:12628480 ]
- LOTUS database [Link]
|
|---|